Published in Oncogene on June 11, 1998
The breast cancer susceptibility gene BRCA1 regulates progesterone receptor signaling in mammary epithelial cells. Mol Endocrinol (2005) 1.52
BRCA1 regulates acetylation and ubiquitination of estrogen receptor-alpha. Mol Endocrinol (2009) 1.43
ZBP-89 promotes growth arrest through stabilization of p53. Mol Cell Biol (2001) 1.43
BRCA1 and BRCA2 as molecular targets for phytochemicals indole-3-carbinol and genistein in breast and prostate cancer cells. Br J Cancer (2006) 1.27
Transcriptional regulation of the base excision repair pathway by BRCA1. J Biol Chem (2010) 1.16
The multisubstrate adapter Gab1 regulates hepatocyte growth factor (scatter factor)-c-Met signaling for cell survival and DNA repair. Mol Cell Biol (2001) 1.13
BRCA1 inhibition of telomerase activity in cultured cells. Mol Cell Biol (2003) 1.12
Tumor suppressor BRCA1 is expressed in prostate cancer and controls insulin-like growth factor I receptor (IGF-IR) gene transcription in an androgen receptor-dependent manner. Clin Cancer Res (2009) 1.08
BRCA1 localization to the telomere and its loss from the telomere in response to DNA damage. J Biol Chem (2009) 1.02
Mycophenolate mofetil modulates adhesion receptors of the beta1 integrin family on tumor cells: impact on tumor recurrence and malignancy. BMC Cancer (2005) 0.95
CRISPR-dCas9 mediated TET1 targeting for selective DNA demethylation at BRCA1 promoter. Oncotarget (2016) 0.93
Phosphatidylinositol 3-kinase/Akt signaling enhances nuclear localization and transcriptional activity of BRCA1. Exp Cell Res (2007) 0.92
Polydatin inhibits growth of lung cancer cells by inducing apoptosis and causing cell cycle arrest. Oncol Lett (2013) 0.86
Identification of nucleolar protein No55 as a tumour-associated autoantigen in patients with prostate cancer. Br J Cancer (2000) 0.85
A paradoxical chemoresistance and tumor suppressive role of antioxidant in solid cancer cells: a strange case of Dr. Jekyll and Mr. Hyde. Biomed Res Int (2014) 0.84
Influence of chemically modified tetracyclines on proliferation, invasion and migration properties of MDA-MB-468 human breast cancer cells. Clin Exp Metastasis (2000) 0.84
Fluorescent oligonucleotides can serve as suitable alternatives to radiolabeled oligonucleotides. J Biomol Tech (2009) 0.83
Increased cell survival by inhibition of BRCA1 using an antisense approach in an estrogen responsive ovarian carcinoma cell line. Breast Cancer Res (2000) 0.83
BRCA1-mediated signaling pathways in ovarian carcinogenesis. Funct Integr Genomics (2011) 0.79
TR4 Nuclear Receptor Alters the Prostate Cancer CD133+ Stem/Progenitor Cell Invasion via Modulating the EZH2-Related Metastasis Gene Expression. Mol Cancer Ther (2015) 0.78
Small-molecule "BRCA1-mimetics" are antagonists of estrogen receptor-α. Mol Endocrinol (2014) 0.77
Synthetic inhibitors of CDKs induce different responses in androgen sensitive and androgen insensitive prostatic cancer cell lines. Mol Pathol (2002) 0.77
A new class of small molecule estrogen receptor-alpha antagonists that overcome anti-estrogen resistance. Oncotarget (2015) 0.76
BRCA1 regulates follistatin function in ovarian cancer and human ovarian surface epithelial cells. PLoS One (2012) 0.75
A role for the dehydrogenase DHRS7 (SDR34C1) in prostate cancer. Cancer Med (2015) 0.75
The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med (1997) 13.96
The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nat Genet (1995) 5.83
Determination of ancestral alleles for human single-nucleotide polymorphisms using high-density oligonucleotide arrays. Nat Genet (1999) 4.79
Detection of heterozygous mutations in BRCA1 using high density oligonucleotide arrays and two-colour fluorescence analysis. Nat Genet (1996) 4.19
The de facto US mental health services system: a public health perspective. Arch Gen Psychiatry (1978) 3.33
Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription. Cell (1999) 3.16
Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci U S A (1993) 2.86
The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%. Nat Genet (1996) 2.82
Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer. Nat Genet (1994) 2.66
Protective efficacy of major outer membrane protein-specific immunoglobulin A (IgA) and IgG monoclonal antibodies in a murine model of Chlamydia trachomatis genital tract infection. Infect Immun (1995) 2.55
BRCA1 inhibition of estrogen receptor signaling in transfected cells. Science (1999) 2.54
The Finland-United States investigation of non-insulin-dependent diabetes mellitus genetics (FUSION) study. I. An autosomal genome scan for genes that predispose to type 2 diabetes. Am J Hum Genet (2000) 2.50
Detection of eight BRCA1 mutations in 10 breast/ovarian cancer families, including 1 family with male breast cancer. Am J Hum Genet (1995) 2.42
The APCI1307K allele and cancer risk in a community-based study of Ashkenazi Jews. Nat Genet (1998) 2.32
The breast cancer information core: database design, structure, and scope. Hum Mutat (2000) 2.19
TIMP-3 binds to sulfated glycosaminoglycans of the extracellular matrix. J Biol Chem (2000) 2.11
BRCA1 interacts with components of the histone deacetylase complex. Proc Natl Acad Sci U S A (1999) 2.10
The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews. Am J Hum Genet (1999) 2.03
Cotransduction and cotransformation of genetic markers in Bacillus subtilis and Bacillus licheniformis. J Bacteriol (1969) 1.98
Expression and generation of interleukin-8, IL-6 and granulocyte-macrophage colony-stimulating factor by bronchial epithelial cells and enhancement by IL-1 beta and tumour necrosis factor-alpha. Immunology (1992) 1.93
Type 2 diabetes: evidence for linkage on chromosome 20 in 716 Finnish affected sib pairs. Proc Natl Acad Sci U S A (1999) 1.91
Evolutionary sequence comparisons using high-density oligonucleotide arrays. Nat Genet (1998) 1.90
A longitudinal study of offset in the use of nonpsychiatric services following specialized mental health care. Med Care (1983) 1.87
Role of direct interaction in BRCA1 inhibition of estrogen receptor activity. Oncogene (2001) 1.82
Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co-localization of eotaxin mRNA to bronchial epithelial and endothelial cells. Eur J Immunol (1997) 1.69
Increases in activated T lymphocytes, eosinophils, and cytokine mRNA expression for interleukin-5 and granulocyte/macrophage colony-stimulating factor in bronchial biopsies after allergen inhalation challenge in atopic asthmatics. Am J Respir Cell Mol Biol (1993) 1.67
Considerations for designing a prototype genetic test for use in translational research. Public Health Genomics (2009) 1.67
Scatter factor and the c-met receptor: a paradigm for mesenchymal/epithelial interaction. J Cell Biol (1994) 1.64
Survival after breast cancer in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst (1999) 1.61
Interspecies transformation between Bacillus subtilis and Bacillus licheniformis. Biochem Biophys Res Commun (1966) 1.57
Splice-mediated insertion of an Alu sequence inactivates ornithine delta-aminotransferase: a role for Alu elements in human mutation. Proc Natl Acad Sci U S A (1991) 1.56
Human ornithine-delta-aminotransferase. cDNA cloning and analysis of the structural gene. J Biol Chem (1988) 1.56
Scatter factor/hepatocyte growth factor protects against cytotoxic death in human glioblastoma via phosphatidylinositol 3-kinase- and AKT-dependent pathways. Cancer Res (2000) 1.56
Levels of vascular endothelial growth factor, hepatocyte growth factor/scatter factor and basic fibroblast growth factor in human gliomas and their relation to angiogenesis. Int J Cancer (1999) 1.52
Expression of interleukin-1beta in human breast carcinoma. Cancer (1997) 1.52
Expression of scatter factor and c-met receptor in benign and malignant breast tissue. Cancer (1997) 1.50
Prednisolone treatment in asthma. Reduction in the numbers of eosinophils, T cells, tryptase-only positive mast cells, and modulation of IL-4, IL-5, and interferon-gamma cytokine gene expression within the bronchial mucosa. Am J Respir Crit Care Med (1996) 1.50
Smooth muscle releases an epithelial cell scatter factor which binds to heparin. In Vitro Cell Dev Biol (1989) 1.48
Alcohol stimulates estrogen receptor signaling in human breast cancer cell lines. Cancer Res (2000) 1.46
Identification of messenger RNA for IL-4 in human eosinophils with granule localization and release of the translated product. J Immunol (1995) 1.42
Cellular senescence in a cloned strain of bovine fetal aortic endothelial cells. Science (1980) 1.41
Three-dimensional structure of Fab R19.9, a monoclonal murine antibody specific for the p-azobenzenearsonate group. Proc Natl Acad Sci U S A (1989) 1.35
At least two mutant alleles of ornithine delta-aminotransferase cause gyrate atrophy of the choroid and retina in Finns. Proc Natl Acad Sci U S A (1989) 1.35
Strand-separating conformational polymorphism analysis: efficacy of detection of point mutations in the human ornithine delta-aminotransferase gene. Genomics (1992) 1.35
A proposed index for measuring agreement in test-retest studies. J Chronic Dis (1966) 1.33
Mortality and migration in multiple sclerosis. Neurology (1971) 1.32
Human BRCA1 inhibits growth in yeast: potential use in diagnostic testing. Proc Natl Acad Sci U S A (1997) 1.32
Epigenetic transfer of metastatic activity by uptake of highly metastatic B16 melanoma cell-released exosomes. Exp Oncol (2006) 1.31
The cytokine hepatocyte growth factor/scatter factor inhibits apoptosis and enhances DNA repair by a common mechanism involving signaling through phosphatidyl inositol 3' kinase. Oncogene (2000) 1.31
Multiple endocrine neoplasia type 1: clinical and genetic features of the hereditary endocrine neoplasias. Recent Prog Horm Res (1999) 1.29
BRCA1 and BRCA2 as molecular targets for phytochemicals indole-3-carbinol and genistein in breast and prostate cancer cells. Br J Cancer (2006) 1.27
Interpreting epidemiological research: blinded comparison of methods used to estimate the prevalence of inherited mutations in BRCA1. J Med Genet (2001) 1.26
Scatter factor promotes motility of human glioma and neuromicrovascular endothelial cells. Int J Cancer (1998) 1.26
Targeted disruption of the methionine synthase gene in mice. Mol Cell Biol (2001) 1.26
Association of perinatal factors with blindness in children. Public Health Rep (1967) 1.24
Development of defined and minimal media for the growth of Bacillus stearothermophilus. J Bacteriol (1975) 1.24
Activation of estrogen signaling pathways collaborates with loss of Brca1 to promote development of ERalpha-negative and ERalpha-positive mammary preneoplasia and cancer. Oncogene (2007) 1.24
CMV enhancer/human PDGF-beta promoter for neuron-specific transgene expression. Gene Ther (2004) 1.23
Cloning, mapping and RNA analysis of the human methionine synthase gene. Hum Mol Genet (1996) 1.23
Screening for mental disorder among primary care patients. Usefulness of the General Health Questionnaire. Arch Gen Psychiatry (1982) 1.21
Purified scatter factor stimulates epithelial and vascular endothelial cell migration. Proc Soc Exp Biol Med (1990) 1.20
Productive infection of Bacillus subtilis 168, with bacteriophage SP-10, dependent upon inducing treatments. J Virol (1968) 1.20
Isolation of mutants of Bacillus stearothermophilus blocked in catabolic function. Can J Microbiol (1973) 1.18
Eosinophils and eosinophil-associated cytokines in allergic inflammation. Int Arch Allergy Immunol (1997) 1.18
TNF alpha mRNA expression in allergic inflammation. Clin Exp Allergy (1991) 1.17
Vascular permeation of platelet factor 4 after endothelial injury. Science (1980) 1.17
Effect of a short-term outpatient psychiatric therapy benefit on the utilization of medical services in a prepaid group practice medical program. Med Care (1970) 1.17
The peroxisome proliferator-activated receptor-gamma2 Pro12A1a variant: association with type 2 diabetes and trait differences. Diabetes (2001) 1.17
In vivo aortic muscle cell growth kinetics. Differences between thoracic and abdominal segments after intimal injury in the rabbit. Circ Res (1980) 1.17
The molecular and cellular basis of radiosensitivity: implications for understanding how normal tissues and tumors respond to therapeutic radiation. Cancer Invest (1999) 1.16
Parkinsonism death rates by race, sex, and geography. Neurology (1988) 1.16
Response of avian embryonic brain to spatially segmented x-ray microbeams. Cell Mol Biol (Noisy-le-grand) (2001) 1.15